SLC9A6 (NHE6): Sodium/Hydrogen Exchanger 6 in Christianson Syndrome and Neurodevelopmental Disorders

A comprehensive biomedical reference for SLC9A6, encoding the endosomal Na+/H+ exchanger NHE6, with emphasis on its role in X-linked intellectual disability, Christianson syndrome, and neuronal pH regulation.

Gene Information Card

Symbol SLC9A6
Full Name Solute carrier family 9 member A6
Gene Type Protein coding
Chromosomal Location Xq26.3
NCBI Gene ID 10479 ncbi.nlm.nih.gov/gene/10479
Ensembl ID ENSG00000198689
UniProt ID Q92581
OMIM ID 300231
HGNC ID 11079
Aliases NHE6, KIAA0267, MGC126562, MGC126564

Description

SLC9A6 encodes sodium/hydrogen exchanger 6 (NHE6), a pH regulator localized primarily to early and recycling endosomes. It mediates electroneutral exchange of Na+ for H+ across endosomal membranes, playing a critical role in maintaining luminal pH homeostasis, endosomal trafficking, and neuronal function. Mutations in SLC9A6 cause Christianson syndrome, an X-linked neurodevelopmental disorder characterized by intellectual disability, epilepsy, ataxia, and microcephaly. The gene is ubiquitously expressed with high levels in brain, particularly in neurons, and is involved in synaptic vesicle recycling and autophagy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Disease Mechanism Evidence
Christianson syndrome Loss-of-function mutations (nonsense, frameshift, splice-site) lead to NHE6 deficiency, causing endosomal acidification defects, impaired neuronal trafficking, and neurodegeneration. ClinVar, OMIM (300243), multiple case reports
X-linked intellectual disability Pathogenic variants in SLC9A6 disrupt endosomal pH regulation, affecting synaptic plasticity and cognitive function. OMIM, HGMD, literature
Epilepsy (often associated with Christianson syndrome) NHE6 dysfunction alters neuronal excitability and synaptic transmission, contributing to seizure phenotypes. ClinVar, case studies
Autism spectrum disorder (in some patients) SLC9A6 mutations may contribute to ASD features through shared neurodevelopmental pathways. ClinVar, research articles
Angelman syndrome-like phenotype Some SLC9A6 mutations present with features overlapping Angelman syndrome (e.g., ataxia, happy demeanor), due to similar endosomal dysfunction. ClinVar, case reports

Expression Profile

Tissue Expression
Tissue nTPM level
Tissue nTPM Level
Brain (cerebral cortex) ~30 High
Cerebellum ~25 High
Heart ~15 Medium
Kidney ~12 Medium
Liver ~8 Low
Lung ~6 Low
Cell Line Expression
Cell Line nTPM Notes
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) ~35 High expression; used for neuronal studies
HeLa (cervical carcinoma) ~20 Moderate expression
HEK293 (embryonic kidney) ~18 Moderate expression; common for transfection
HepG2 (hepatocellular carcinoma) ~10 Low expression
A549 (lung carcinoma) ~8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
Variant Type Frequency Effect
c.1092_1093del (p.Glu365Aspfs*3) Frameshift Rare (found in multiple families) Loss of function; truncated protein, likely degraded
c.1264C>T (p.Arg422*) Nonsense Rare Loss of function; premature stop codon
c.1568+1G>A Splice-site Rare Loss of function; aberrant splicing, likely exon skipping
c.1696C>T (p.Arg566Trp) Missense Rare Uncertain; may affect protein stability or function
c.2146G>A (p.Gly716Arg) Missense Rare Uncertain; possibly hypomorphic
Mutation functional classification

Loss of Function (LOF)

Most pathogenic SLC9A6 mutations are loss-of-function, including nonsense, frameshift, and splice-site variants that lead to NHE6 protein truncation or absence, resulting in endosomal pH dysregulation and Christianson syndrome.

Gain of Function (GOF)

No gain-of-function mutations have been reported for SLC9A6 in the literature or databases.

Dominant Negative (DN)

Given the X-linked inheritance and hemizygosity in males, dominant-negative effects are not typically described; however, some missense variants might exert a dominant-negative effect in females due to X-inactivation skewing, but evidence is limited.

Gene Ontology (GO)

• Sodium:proton antiporter activity • Potassium:proton antiporter activity
• Endosome membrane • Early endosome
• Recycling endosome • Neuronal cell body
• Dendrite • Axon
• pH regulation • Endosomal transport
• Synaptic vesicle recycling • Autophagy

Pathways

Endosomal acidification and trafficking
Neurotransmitter release and synaptic vesicle recycling
Autophagy pathway
mTOR signaling (indirectly via amino acid sensing)

Protein Summary

NHE6 (Na+/H+ exchanger 6) is a 701-amino acid multi-pass transmembrane protein with 10-12 predicted transmembrane helices. It localizes to early and recycling endosomes, where it catalyzes the electroneutral exchange of Na+ for H+, thereby regulating endosomal pH. NHE6 has a long cytoplasmic C-terminal tail containing PDZ-binding motifs that mediate protein-protein interactions. It is highly expressed in neurons, where it is essential for maintaining proper endosomal pH during synaptic vesicle recycling and receptor trafficking. Defects in NHE6 lead to endosomal hyperacidification, impaired neuronal function, and neurodegeneration.

Related Products

Product name Cat.No. Species Gene ID
SLC9A6 Knockout HEK293 Cell Line EDJ-KQ7057 Human 10479 Details Get a Quote
SLC9A6 Knockout HeLa Cell Line EDJ-KQ18240 Human 10479 Details Get a Quote
SLC9A6 Knockout A-549 Cell Line EDJ-KQ31857 Human 10479 Details Get a Quote
SLC9A6 Knockout HCT 116 Cell Line EDJ-KQ31858 Human 10479 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: